BRIEF published on 05/27/2024 at 07:53, 2 years 2 months ago Ernst Russ AG: Stable Development in the First Quarter of 2024 Quarter Results Ernst Russ AG Maritime Investment 2024 Financial Outlook Container Vessels
BRIEF published on 05/27/2024 at 07:35, 2 years 2 months ago EUROPLASMA: New milestone reached for the Field Intelligence Energy subsidiary Technology Investment Europlasma Field Intelligence Energy Green Barrel
BRIEF published on 05/27/2024 at 07:35, 2 years 2 months ago EUROPLASMA: New milestone reached for the Field Intelligence Energy subsidiary Decarbonization Latin America Europlasma Field Intelligence Energy Green Barrel
BRIEF published on 05/27/2024 at 07:35, 2 years 2 months ago Netgem organizes a videoconference for its individual shareholders Shareholders Strategy Annual Results Videoconferencing Netgem
BRIEF published on 05/27/2024 at 07:35, 2 years 2 months ago Alstom Executes Final Step of €2 Billion Deleveraging Plan with €1 Billion Capital Increase Capital Increase Subscription Rights Alstom Deleveraging Plan
BRIEF published on 05/27/2024 at 07:35, 2 years 2 months ago McPhy Energy: Hytlantic and McPhy Agree to Terminate Cooperation Agreement Electrolyzers Hydrogen McPhy Energy Hytlantic GreenH2Atlantic
BRIEF published on 05/27/2024 at 07:05, 2 years 2 months ago Baloise Swiss Property Fund records strong operating result for the first half of 2023/2024 Real Estate Capital Increase Baloise Half-year Results Renovation Projects
BRIEF published on 05/27/2024 at 07:05, 2 years 2 months ago TAG Immobilien AG Rated Investment Grade by Both S&P Global and Moody's Moody's Financial Policy TAG Immobilien AG Investment Grade S&P Global
BRIEF published on 05/27/2024 at 07:05, 2 years 2 months ago Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH and OCT Clinical GmbH Merger Clinical Research Europe Healthcare Xlife Sciences
BRIEF published on 05/27/2024 at 07:05, 2 years 2 months ago FDA Grants Priority Review to Sarclisa for Treatment of Multiple Myeloma FDA Sanofi Multiple Myeloma Sarclisa Chemotherapy
Published on 08/10/2026 at 14:30, 48 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 1 hour 48 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 2 hours 18 minutes ago Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Published on 08/10/2026 at 13:00, 2 hours 18 minutes ago Azarga Metals Mobilizes Drill Rig and Ancillary Equipment to Marg Project, Yukon
Published on 08/10/2026 at 13:00, 2 hours 18 minutes ago NioCorp to Host Webcast on Aug. 11 to Discuss Elk Creek Feasibility Study Results
Published on 08/10/2026 at 15:03, 15 minutes ago Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 08/10/2026 at 14:35, 43 minutes ago Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.81 Million Tokens, and Total Crypto and Total Cash Holdings of $11.6 Billion
Published on 08/10/2026 at 14:31, 47 minutes ago Heimo Scheuch decides to resign early as CEO of wienerberger for personal health reasons, Gerhard Hanke appointed Interim CEO
Published on 08/10/2026 at 14:30, 48 minutes ago Fitch Ratings upgrades outlook for Fresenius SE from stable to positive
Published on 08/10/2026 at 11:53, 3 hours 24 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 3 hours 41 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 5 hours 56 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 07:00, 8 hours 18 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/07/2026 at 18:54, 2 days 20 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
